20 / 20 Blog Archive
Feb 13 2019 | Posted In: 20/20 Blog
Palo Alto, CA — Byers Eye Institute was recently selected to join the Foundation Fighting Blindness Consortium (FFB). The FFB Consortium was created to standardize care for patients with rare inherited retinal disorders across institutions in centers of excellence so they are better candidates for...
Feb 4 2019 | Posted In: 20/20 Blog
Palo Alto, CA — How can physicians and scientists make clinical trials faster, cheaper, and more likely to succeed? The answer may be proteomic analysis. This largescale study of proteins is showing the real time molecular makeup of blinding eye diseases and revealing specific diagnoses that can...
Feb 1 2019 | Posted In: 20/20 Blog
Charlotte, NC — David Almeida MD, MBA was recently featured in Retina Today's 5 Questions section. In his article, A Brief Guide to Choroidal Hemorrhages, he gives excellent surgical insight and techniques.
Jan 17 2019 | Posted In: 20/20 Blog
Gangzhou, China —A delegation of eight Stanford Byers Eye Institute physicians and scientists, Jeffrey Goldberg, Quan Dong Nguyen, Daniel Palanker, Michael Kapiloff, Y. Joyce Liao, and Vinit Mahajan, traveled to Zhongshan Ophthalmic Center (ZOC) of Sun Yat-sen University for a Joint Symposium of...
Dec 14 2018 | Posted In: 20/20 Blog
Palo Alto, CA —
Why volunteer for a clinical trial?
The rigorous process of turning a new therapy into the standard of care depends on patient volunteers.
Ophthalmology clinical trials make it possible for new therapies for currently untreatable eye diseases to leave the laboratory for the clinic...
